Drawing for NOVOCARE

USPTO serial 74169294

NOVOCARE

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
Examiner
MANVILLE, ANNA W.
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with NOVOCARE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
009computer programs in the field of pharmaceutical products for treating diabetesABANDONED
016informational medical brochures about diabetes and pharmaceutical products for treating diabetesABANDONED
041educational services; namely, conducting seminars about diabetes and pharmaceutical products for treating diabetesABANDONED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 27, 1993ABN5ABANDONMENT - AFTER PUBLICATION
Aug 4, 1992PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 2, 1992NPUBNOTICE OF PUBLICATION
Apr 27, 1992CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Apr 22, 1992CNEAEXAMINER'S AMENDMENT MAILED
Mar 3, 1992CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 3, 1991CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 10, 1991DOCKASSIGNED TO EXAMINER

Frequently asked questions

Related guidance